What does a diagonal earlobe crease (Frank's sign) indicate about cardiovascular risk, and what evaluation and preventive measures should be recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diagonal Earlobe Crease (Frank's Sign) and Cardiovascular Risk

A diagonal earlobe crease (Frank's sign) is a marker of increased cardiovascular risk that should prompt comprehensive cardiovascular risk assessment using validated tools (Framingham, PREVENT, or Pooled Cohort Equations) and aggressive management of modifiable risk factors, particularly in patients with bilateral, deep creases.

What Frank's Sign Indicates

Frank's sign represents an independent cardiovascular risk marker associated with:

  • Coronary artery disease: Bilateral DELC shows independent association with obstructive CAD (OR 1.36,95% CI 1.07-1.74) 1
  • Cerebrovascular events: Present in 78.8% of acute stroke patients, with significantly higher prevalence in cerebrovascular accidents (88.6%) versus transient ischemic attacks (73.2%, P <0.01) 2
  • Elevated cardiovascular risk scores: Individuals with bilateral creases have 58% prevalence of moderate-to-very-high cardiovascular risk versus 23.8% without creases (P <0.001) 3

The crease severity matters—longest, deepest, bilateral creases with accessory creases correlate with highest cardiovascular risk 3.

Key Risk Factors Associated with Frank's Sign

The strongest independent associations are 4:

  • Age >55 years (OR 4.8,95% CI 3.2-7.2)
  • Male sex (OR 1.6-2.04)
  • Obesity (OR 2.1,95% CI 1.4-3.1)
  • Arterial hypertension (OR 1.5,95% CI 1.1-2.3)
  • Acute coronary syndrome (OR 5.3,95% CI 2.5-11.1)

Recommended Evaluation Algorithm

1. Immediate Risk Stratification

Calculate 10-year cardiovascular risk using 5:

  • Framingham Risk Score or
  • Pooled Cohort Equations or
  • PREVENT equations (most recent)

Target threshold: ≥7.5% 10-year risk warrants intensive intervention 6.

2. Traditional Risk Factor Assessment 7

Measure at baseline:

  • Blood pressure (target <140/85 mmHg, <130/80 mmHg if diabetic) 8
  • Fasting lipid panel (target total cholesterol <5.0 mmol/L, LDL <3.0 mmol/L) 8
  • Fasting glucose/HbA1c
  • Body mass index and waist circumference
  • Smoking status

3. Consider Risk-Enhancing Factors 9

Particularly relevant with Frank's sign:

  • Family history of premature ASCVD (males <55y, females <65y)
  • Chronic kidney disease (eGFR 15-59 mL/min/1.73 m²)
  • Metabolic syndrome
  • Chronic inflammatory conditions

4. Additional Testing for Intermediate Risk (5-7.5%) 5

When risk calculation is borderline:

  • 12-lead ECG (Class I recommendation) to screen for left ventricular hypertrophy 6
  • Consider coronary artery calcium (CAC) scoring if ≥40 years with diabetes 10
  • High-sensitivity C-reactive protein (>2.0 mg/L indicates increased risk) 5

Preventive Interventions

For ALL Patients with Frank's Sign 8, 9:

Lifestyle modifications:

  • Smoking cessation (mandatory)
  • Mediterranean or DASH diet
  • ≥150 minutes/week moderate-intensity aerobic exercise
  • Weight loss if BMI ≥25 kg/m²
  • Alcohol moderation

Pharmacologic Therapy Based on Risk 11, 8:

High risk (≥15% 10-year risk) or established CVD:

  • Aspirin 75-100mg daily (unless contraindicated)
  • Statin at doses from clinical trials (high-intensity if very high risk)
  • ACE inhibitor (particularly if hypertensive, diabetic, or post-MI)
  • Beta-blocker if prior MI

Intermediate risk (7.5-15%):

  • Statin therapy if LDL ≥70 mg/dL after lifestyle modification
  • Antihypertensive therapy if BP ≥140/90 mmHg (≥130/80 if diabetic) after 3-6 month lifestyle trial 6
  • Consider aspirin if bleeding risk is low

Blood pressure targets 8, 6:

  • General population: <140/85 mmHg
  • Diabetes: <130/80 mmHg (<125/75 if proteinuria)
  • Consider intensive BP lowering (systolic <120 mmHg) in very high-risk patients

Critical Caveats

Frank's sign has modest diagnostic accuracy as a stand-alone marker 1—it reflects underlying cardiovascular risk burden rather than serving as an independent diagnostic tool 12. The sign's presence increases with age and may simply represent aging-related connective tissue changes 4.

Do not use Frank's sign alone to make treatment decisions. Always integrate it with validated risk calculators and traditional risk factors 5. The sign is most useful for identifying patients who warrant comprehensive cardiovascular evaluation 13, not as a screening tool for the general population.

Bilateral, deep creases warrant more aggressive risk factor assessment and management than unilateral or superficial creases 3.

References

Research

Diagonal earlobe crease (Frank's sign) and increased risk of cerebrovascular diseases: review of the literature and implications for clinical practice.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.